📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review (2021)

First Author: Walsh Z

Attributed to: Reducing relapse in alcohol dependence with the NMDA receptor antagonist, ketamine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1192/bjo.2021.1061

PubMed Identifier: 35048815

Publication URI: http://europepmc.org/abstract/MED/35048815

Type: Journal Article/Review

Parent Publication: BJPsych Open

Issue: 1

ISSN: 2056-4724